首页> 外文OA文献 >The EUTOS prognostic score: review and validation in 1288 patients with CML treated frontline with imatinib

【2h】

The EUTOS prognostic score: review and validation in 1288 patients with CML treated frontline with imatinib

机译：Eutos预后评分：1288例CML治疗前线与伊马替尼的审查和验证

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
V S Hoffmann; M Baccarani; D Lindoerfer; F Castagnetti; A Turkina; A Zaritsky; A Hellmann; W Prejzner; J-L Steegmann; J Mayer; K Indrak; A Colita; G Rosti; M Pfirrmann;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. EUTOS CML prognostic scoring system predicts ELN-based 'event-free survival' better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate [J] . UzB., BuyukasikY., AtayH., Hematology. . 2013,第5期

机译：EUTOS CML预后评分系统预测接受一线甲磺酸伊马替尼治疗的CML患者基于ELN的“无事件生存”优于Euro / Hasford和Sokal系统
2. EUTOS CML prognostic scoring system predicts ELN-based ‘event-free survival’ better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate [J] . Burak Uz, Yahya Buyukasik, Hilmi Atay, Hematology . 2013,第5期

机译：在接受一线甲磺酸伊马替尼治疗的CML患者中，EUTOS CML预后评分系统预测基于ELN的“无事件生存”优于Euro / Hasford和Sokal系统
3. Moderate anemia at diagnosis is an independent prognostic marker of the EUTOS, Sokal, and Hasford scores for survival and treatment response in chronic-phase, chronic myeloid leukemia patients with frontline imatinib [J] . Ko Po-Shen, Yu Yuan-Bin, Liu Yao-Chung, Current medical research and opinion . 2017,第10期

机译：诊断中适度的贫血是慢性阶段慢性阶段的慢性阶段的生存和治疗反应的独立预后标志物，慢性骨髓白血病患者的慢性癌症
4. A bioinformatics pipeline for sequence to structure: A case study with a Cml patient undergoing treatment with imatinib [C] . Chacko Anita Rachel, Patil Shankarrao, Upadhayay Atul K., 2013 Biomedical Sciences and Engineering Conference . 2013

机译：用于构建序列的生物信息学流水线：以接受伊马替尼治疗的Cml患者为例
5. Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study [D] . Harada Yasuhiko, 原田靖彦 2019

机译：根据2017年日本成人白血病研究组（JALSG）AML201研究治疗的成人急性髓性白血病患者的遗传学预测，根据2017 ELN风险分层进行预后分析
6. Validation of the EUTOS Long-Term Survival Score in Chinese Chronic Myeloid Leukemia Patients Treated with Imatinib: A Multicenter Real-World Study [O] . Xiawan Yang, Yanliang Bai, Mingyue Shi, 2020

机译：伊马替尼治疗的中国慢性粒细胞白血病患者的EUTOS长期生存评分的验证：一项多中心真实世界研究
7. >Validation of the EUTOS Long-Term Survival Score in Chinese Chronic Myeloid Leukemia Patients Treated with Imatinib: A Multicenter Real-World Study [O] . Xiawan Yang, Yanliang Bai, Mingyue Shi, 2020

机译：>核糖核苷酸长期存活评分在伊马替尼治疗的中国慢性骨髓性白血病患者中的长期存活评分：多中心真实世界研究

The EUTOS prognostic score: review and validation in 1288 patients with CML treated frontline with imatinib

著录项

引文网络

相似文献

相关主题

期刊订阅